PhotoPill Medical
Disposable Electronic Capsule for side-effect-free treatment of Crohn's Disease.
Company Overview
Snapshot
Founded in July 2010 by Ram Ben-Yehuda and Sharon Ben Yehuda, PhotoPill Medical operates with 1–10 employees. The company has raised $3.2M across four funding rounds and holds one patent. In May 2025, PhotoPill Medical launched a clinical study for its IBD-Cap capsule with Crohn’s Disease patients.
Business overview
PhotoPill Medical develops an electronic, disposable, non-medicinal capsule utilizing Photo-Bio Modulation treatment (PBMt) to manipulate gut-microbiota. This technology aims to treat conditions affected by gut-microbiota, with its initial product, IBD-Cap, designed to reduce flare-ups and treat ulcerations and inflammation associated with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease. The capsule operates autonomously, serving the Health Tech & Life Sciences sector, specifically within Medical Devices and Digital Healthcare, targeting both B2B and B2C markets globally.
Strategic signal
In May 2025, PhotoPill Medical initiated a clinical study for its IBD-Cap capsule with Crohn’s Disease patients. This development signals a critical advancement in the company's product validation and regulatory pathway, demonstrating progress towards bringing its novel Photo-Bio Modulation therapy to market for inflammatory bowel diseases. For investors, this indicates a significant step in de-risking the technology and moving closer to commercialization within the therapeutic devices market.
Company Intelligence Q&A
- What is PhotoPill Medical's core product?
- PhotoPill Medical's core product is the IBD-Cap, a disposable, ingestible electronic capsule designed to deliver Photo-Bio Modulation (PBM) therapy for the treatment of inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease.
- When was PhotoPill Medical founded?
- PhotoPill Medical was founded in July 2010.
- Who are the founders of PhotoPill Medical?
- PhotoPill Medical was founded by Ram Ben-Yehuda and Sharon Ben Yehuda.
- What is the total capital raised by PhotoPill Medical?
- PhotoPill Medical has raised a total of $3.2M across four funding rounds.
- What was a significant recent development for PhotoPill Medical?
- In May 2025, PhotoPill Medical launched a clinical study for its IBD-Cap capsule with Crohn’s Disease patients, marking a key step in its product development and validation.